Please select the eligibility criteria that correspond to the clinical trial below.
Title: Integrated Care for Inflammatory Bowel Disease Patients in the Netherlands With the Novel Telemedicine Tool myIBDcoach: a Randomized Controlled Trial
Brief Summary: Inflammatory bowel diseases (IBD) is an invalidating disease mainly diagnosed in young people. The disease is characterized by a heterogenic phenotype and the disease course by flares and remissions. As in most chronic diseases the economic burden of IBD is important due to direct health care costs and disability. Health care reorganization for IBD patients in the Netherlands is necessary for several reasons. First chronic (sub)clinical mucosal inflammation results in irreversible bowel damage and complications and none of the presently available drugs is effective for all patients and many drugs have possible severe side effects. To prevent complications of the disease and side effects IBD should be monitored carefully. In the Netherlands however there is a shortage of gastroenterologists where the incidence of IBD is rising. Secondly evidence exists that direct involvement of health care workers, patient empowerment and integrated care can improve the outcome of chronic diseases. Thirdly many clinically relevant aspects (e.g. malnutrition) of this complex disease are not systematically followed in routine care. Finally the government demands registration of efficacy endpoints for expensive drugs in the near future. Therefore the investigators developed a web-based Telemedicine tool for IBD patients in collaboration with the Dutch IBD patient's organization (CCUVN). "myIBcoach" contains E-learning modules, monitors disease activity, disability, quality of life, adherence, infections, smoking status, side effects, stress and malnutrition on fixed time points with validated questionnaires, allows the patient to communicate with health care workers and gives feedback to the back office and the patient. A feasibility study in 30 IBD patients in 3 centres showed a high satisfaction and compliance of IBD-patients and health care workers with this telemedicine tool.

The aim of this study is to compare standard care for IBD patients in 3 hospitals with a care via the telemedicine tool myIBDcoach.


Options:
A: Inclusion Criteria:

* patient age 11-18 years
* patient English speaking
* patient legal guardian willing to participate
* patient on oral IBD maintenance medication for 3 months or longer

Exclusion Criteria:

* history of significant parent-reported cognitive or developmental delay
B: Inclusion Criteria:

* patients aged between 8 and 16 years
* diagnosis of IBD by established clinical, endoscopic, histological and radiological criteria
* clinical remission defined as an abbreviated Paediatric Crohn's Disease Activity Index (aPCDAI) score of ≤10 for patients with Crohn's disease or as a Paediatric Ulcerative Colitis Activity Index (PUCAI) score of \<10 for those with ulcerative colitis and indeterminate colitis
* parental and child's consent to participate in the study.

Exclusion Criteria:

* active disease (aPCDAI\>15 or PUCAI ≥15)
* unwillingness to provide informed consent.
C: Inclusion Criteria:

* Patients aged ≥18 years.
* Inflammatory Bowel Disease at least 6 months duration, diagnosed according to the classical criteria of Lennard-Jones
* Patients with Crohn's Disease or Ulcerative Colitis with moderate or severe activity (as Harvey-Bradshaw index and May, respectively) attending IBD unit during the period of inclusion.
* Patients who initiate medical treatment with immunosuppressive drugs or biological agents, or are undergoing surgical treatment (surgery is considered as a treatment for EC).
* Patient consents to participate in the study and sign and date personally indicating that it has been informed of all pertinent aspects of the study.
* Patient not incur the exclusion criteria

Exclusion Criteria:

* Patients with cognitive or sensory impairments or with insufficient command of the two official languages of Valencia, in the opinion of the health professional conduct recruitment, hinder the understanding of the issues raised in the surveys, scales or instruments used in the study always who do not have a legal representative
* Patients who are unable to handle a mobile phone to participate in the study. - Patients who do not have a phone line because, if they are assigned to G_TECCU or G_AT groups could not be implemented appropriate interventions.
* They are participating at the time of recruitment in any other clinical trial or experimental study. Exclusion criteria will not be participating in observational studies
* Terminals and / or palliative care according to the criteria of the SECPAL (Spanish Society of Palliative Care) Patients
* Patients institutionalized
* They are members of the research team, the staff of the research center or health centers involved in the study, or any other person directly involved in the study.
* Relatives in the first degree of consanguinity or affinity of members of the research team, the staff of the research center or health centers involved in the study, or any other person directly involved in the study
* Patients presenting as primary diagnosis mental illness
* Patients with active cancer diagnosis
* Patients in the assessment of professional performing recruitment not considered likely to be included for specific monitoring found in another unit such as hemodialysis, transplant unit, day hospital ...
* Patients who do not agree to participate in the study or not to sign the corresponding informed consent
D: Inclusion Criteria:

* Diagnosed IBD
* Age 18-75 years
* Patients who have access to internet by computer, tabloid or smartphone

Exclusion Criteria:

* Not able to give informed consent
* Not able to understand and use the Dutch language
* In the two weeks after a hospital admission patients can not be included

Answer: D